Cargando…

Bioorthogonal Small Molecule Imaging Agents Allow Single-Cell Imaging of MET

The hepatocyte growth factor receptor (MET) is a receptor tyrosine kinase (RTK) that has emerged as an important cancer target. Consequently, a number of different inhibitors varying in specificity are currently in clinical development. However, to date, it has been difficult to visualize MET expres...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Eunha, Yang, Katherine S., Weissleder, Ralph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827223/
https://www.ncbi.nlm.nih.gov/pubmed/24265843
http://dx.doi.org/10.1371/journal.pone.0081275